Central Library, KUET

Your cart is empty.
Khulna University of Engineering & Technology
Central Library

Normal view MARC view ISBD view

Emerging therapeutic targets in ovarian cancer / Stan Kaye [and others], editors.

Contributor(s): Kaye, Stanley B.
Material type: materialTypeLabelBookPublisher: New York : Springer Science+Business Media, LLC, ©2011Description: 1 online resource (xiii, 291 pages) : illustrations.Content type: text Media type: computer Carrier type: online resourceISBN: 9781441972163; 1441972161; 9781441972156; 1441972153.Subject(s): Ovaries -- Cancer -- Treatment | Ovarian Neoplasms -- therapy | Antineoplastic Agents -- therapeutic use | Drug Design | Drug Therapy -- trends | Medicine | HEALTH & FITNESS -- Diseases -- Cancer | MEDICAL -- Oncology | Ovaries -- Cancer -- TreatmentGenre/Form: Electronic books.Additional physical formats: Print version:: Emerging therapeutic targets in ovarian cancer.DDC classification: 616.99/465 Online resources: Wiley Online Library
Contents:
Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
Summary: This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Includes bibliographical references and index.

Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.

This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.

Print version record.

There are no comments for this item.

Log in to your account to post a comment.

Khulna University of Engineering & Technology
Funded by: HEQEP, UGC, Bangladesh